Diagnostic Biomarkers for Checkpoint Inhibitor-related Pneumonitis
Recruiting now
Conditions studied: Checkpoint Inhibitor-related Pneumonitis
In brief
Checkpoint inhibitor-related pneumonitis (CIP) is a common fatal immune-related adverse events of PD-1/PD-L1 inhibitors. Early diagnosis of CIP is crucial for timely intervention and improved prognosis; however, the absence of precise and effective diagnostic techniques often leads to underdiagnosis and misdiagnosis. The investigators conducted a prospective clinical study to evaluate the effectiveness of ¹H-nuclear magnetic resonance (NMR)-based lipoprotein and metabolite analysis in diagnosing checkpoint inhibitor-related pneumonitis (CIP), aiming to improve its early diagnosis rate.
Key facts
- Study ID
- NCT07340892
- Run by
- Zhou Chengzhi
- People needed
- 60
- Starts
- 2026-01-10
- Expected to finish
- 2028-01-10
- Last updated by the study team
- 2026-02-04
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients with a pathological diagnosis of lung cancer;
- The subject has received at least one course of immune checkpoint inhibitor treatment;
- Capable of understanding and voluntarily signing an informed consent form.
- For the CIP group, the following additional criteria must be met:
- Highly suspected of having checkpoint inhibitor pneumonitis based on radiological abnormalities and/or pulmonary symptoms (including fever, cough, and dyspnea).
- For the Control group, the following additional criteria must be met:
- Has had no clinical symptoms or radiographic evidence suggestive of pneumonitis at enrollment or prior to enrollment.
You may not qualify if…
- Pulmonary lesions were definitively diagnosed as tumor progression, bacterial pneumonia, or pulmonary edema;
- Incomplete or missing follow-up data.
Where it is running
- The First Affiliated Hospital of Guangzhou Medical University — Guangzhou, Guangdong, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.